Diagnostics company releases biomarker panel for type 1 diabetes detection

08/16/2013 | MedCityNews.com

Genalyte has introduced its first biomarker panel that can detect type 1 diabetes early by measuring seven autoantibodies linked to destroyed pancreatic islet cells seen in patients with the condition. The disposable silicon chip-based test, which takes only 15 minutes to generate results, was developed using a $500,000 Small Business Innovation Research grant received by the company last year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC